In the second half of his Maui Derm recap, George Martin, MD, founder and program director of the meeting, highlights new ...

A phase 3 trial shows that apremilast, an oral phosphodiesterase 4 inhibitor, improves symptoms, disease severity, and ...

Among patients with psoriasis who have active or recent cancer, biologic therapies show similar cancer progression or recurrence and serious infection rates compared with conventional systemic agents.

ASAS-PerSpA study finds Japanese patients with axial psoriatic arthritis have lower disease activity and better function than ...

Courtney is a registered nurse with over 13 years of experience in the clinical setting, helping individuals navigate their way through their healthcare journeys. She has been in the frontlines ...

Vixarelimab showed significant symptom relief and disease progression reduction in prurigo nodularis compared with placebo across all doses. A phase 2b trial found vixarelimab rapidly reduced itch and ...